Literature DB >> 16847907

Effects of antenatal magnesium sulfate and corticosteroid therapy on sleep states of preterm infants.

Beth Black1, Diane Holditch-Davis, Todd Schwartz, Mark S Scher.   

Abstract

This exploratory longitudinal study was designed to compare the neonatal illness severity, sleep-wake, and respiratory sleep behaviors of preterm infants whose mothers received prenatal corticosteroids and/or magnesium sulfate (MgSO4) with those of infants whose mothers did not receive these medications. The 134 infants were divided into four groups: those whose mothers received MgSO4 only, those who received steroids only, those who received both MgSO4 and steroids, and those who received neither. The groups did not differ on infant characteristics or illness severity. Infants exposed to MgSO4 had more active sleep without rapid eye movement, indicating poorly organized active sleep. The MgSO4 -only group had higher quiet sleep regularity scores and fewer state changes. These findings suggest that fetal exposure to MgSO4 may subtly affect the central nervous system. Copyright 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847907     DOI: 10.1002/nur.20141

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  3 in total

1.  Newborns' sleep-wake cycle development on amplitude integrated electroencephalography.

Authors:  Xu-Fang Li; Yan-Xia Zhou; Lian Zhang
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

Review 2.  The relationship between micronutrient status and sleep patterns: a systematic review.

Authors:  Xiaopeng Ji; Michael A Grandner; Jianghong Liu
Journal:  Public Health Nutr       Date:  2016-10-05       Impact factor: 4.022

3.  Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis.

Authors:  Emily Shepherd; Rehana A Salam; Deepak Manhas; Anne Synnes; Philippa Middleton; Maria Makrides; Caroline A Crowther
Journal:  PLoS Med       Date:  2019-12-06       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.